Institute for International Research

Dear Colleague,

As we enter the 7th year of our Immunogenicity Studies for Biotherapeutics conference, our faculty remains committed to bringing you the latest new data and clarification on emerging regulatory guidances for assay development and validation in immunogenicity studies.

This conference provides you leading-edge information on new technologies to identify, characterize and reduce antibody and cell-based responses during discovery, development, pre-clinical and clinical studies. Case studies with new data on selection, development and validation of screening, neutralizing, and confirmatory assays in processes and techniques improvement strategies are featured over all three days of the conference.

As IIR specializes in the development of Immunogenicity conferences, we recognize the evolving challenges faced by scientists working on immunogenicity studies and make it our top priority to be first at providing new immunogenicity study data and solutions.

For registration information, early registration prices and group discounts, please click here. We look forward to welcoming you to the conference in San Francisco.

Sincerely,

Anne Reel, Program Director, IIR

Valerie Bowling, General Manager, IIR